Loading...
  • development
  • Thus, a rough estimate of costs and development time for repositioned drugs to reach the market is 300 million US$ and 6 years, respectively [ 5 ], which still appears not to be satisfactory, but definitely competitive in comparison to the development ab initio of new therapeutic agents. (biomedcentral.com)
  • therapeutic
  • Thus, a rough estimate of costs and development time for repositioned drugs to reach the market is 300 million US$ and 6 years, respectively [ 5 ], which still appears not to be satisfactory, but definitely competitive in comparison to the development ab initio of new therapeutic agents. (biomedcentral.com)